Company news

Daito Pharmaceutical Co., Ltd. news in 2026

Daito Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Notice Regarding Repurchase of Own Shares

November 2, 2026

[Summary] Summary of Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP)

October 14, 2026

Notice Concerning the Acquisition of Treasury Shares and the Cancellation of Treasury Shares

October 14, 2026

FY2027 1Q Earnings Presentation

October 14, 2026

Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical's Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ

September 30, 2026

FY2026 4Q Earnings Presentation

July 15, 2026

Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3)

July 12, 2026

Summary of Consolidated Financial Results for the Fiscal Year Ended May 31,2026 (Under Japanese GAAP)

July 10, 2026

Summary of Consolidated Financial Results for the Six Months Ended November 30, 2025 (Under Japanese GAAP)

January 14, 2026

Decks in 2026